...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: TNBC Competition
Reply New Message
Back To Forum List View
TNBC Competition
1
Toinv
Feb 20, 2023 11:41AM
Re: TNBC Competition
3
KOO-KOO2
Feb 20, 2023 03:05PM

"If this promising new approach is validated in clinical trials, it could significantly change the treatment landscape for people with this aggressive cancer and help them live longer."

 
Toinv, ....Which trial is being referred to in your post?      Who is the sponsor?      Who is the competition to Zenith?
 
 
Koo
Re: TNBC Competition

Toinv
Feb 21, 2023 12:10PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply